• Citer

A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study.

par Villanueva, C.;Awada, Ahmad ;Campone, Mario;Machiels, Jean Pascal;Besse-Hammer, Tatiana;Magherini, E;Dubin, F;Semiond, D;Pivot, X
Référence European journal of cancer, 47, 7, page (1037-1045)
Publication Publié, 2011-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study.
Auteur:	Villanueva, C.; Awada, Ahmad; Campone, Mario; Machiels, Jean Pascal; Besse-Hammer, Tatiana; Magherini, E; Dubin, F; Semiond, D; Pivot, X
Informations sur la publication:	European journal of cancer, 47, 7, page (1037-1045)
Statut de publication:	Publié, 2011-05
Sujet CREF:	Cancérologie
MeSH keywords:	Adult
	Aged
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Area Under Curve
	Breast Neoplasms -- drug therapy
	Deoxycytidine -- administration & dosage -- analogs & derivatives
	Drug Resistance, Neoplasm
	Female
	Fluorouracil -- administration & dosage -- analogs & derivatives
	Humans
	Maximum Tolerated Dose
	Middle Aged
	Neoplasm Metastasis
	Taxoids -- administration & dosage
	Treatment Outcome
Note générale:	Clinical Trial, Phase II
	Clinical Trial, Phase III
	Journal Article
	Multicenter Study
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2011.01.001
	info:pii/S0959-8049(11)00018-9
	info:scp/79953713649
	info:pmid/21339064